Effect of warfarin versus aspirin on the incidence of new thromboembolic stroke in older persons with chronic atrial fibrillation and abnormal and normal left ventricular ejection fraction

American Journal of Cardiology

Volumn 85, Issue 8, 2000, Pages 1033-1035

  Aronow, Wilbert S ^a,b   Ahn, Chul ^c   Kronzon, Itzhak ^d   Gutstein, Hal ^a  

^a HEBREW HOSPITAL HOME   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AGED; BRAIN HEMORRHAGE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEMATURIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SHORT SURVEY; STROKE; THROMBOEMBOLISM;

EID: 0034656369     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00928-5     Document Type: Article

References (7)

1. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation. II. Echocardiocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
2. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.
3. Aronow W.S., Ahn C., Kronzon I., Gutstein H. Risk factors for new thromboembolic stroke in persons ≥62 years old old with chronic atrial fibrillation. Am J Cardiol. 82:1998;119-121.
4. Peterson P., Boysen G., Godtfredsen J., Andersen E.D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet. 1:1989;175-179.
5. Aronow W.S., Ahn C., Kronzon I., Gutstein H. Incidence of new thromboembolic stroke in persons ≥62 years old with chronic atrial fibrillation treated with warfarin versus aspirin. J Am Geriatr Soc. 47:1999;366-368.
6. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
7. Aronow W.S., Ahn C., Kronzon I. Prevalence of echocardiographic findings in 554 men and in 1,243 women aged >60 years in a long-term health care facility. Am J Cardiol. 79:1997;379-380.